Reviews - 3j6u mentioned but not cited (2)
- Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design. Crowe JE. Cell Host Microbe 22 193-206 (2017)
- Mapping the diverse structural landscape of the flavivirus antibody repertoire. Sevvana M, Kuhn RJ. Curr Opin Virol 45 51-64 (2020)
Articles - 3j6u mentioned but not cited (9)
Reviews citing this publication (49)
- New insights into the immunopathology and control of dengue virus infection. Screaton G, Mongkolsapaya J, Yacoub S, Roberts C. Nat. Rev. Immunol. 15 745-759 (2015)
- Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control. Diamond MS, Pierson TC. Cell 162 488-492 (2015)
- Zika Virus: Immunity and Vaccine Development. Pierson TC, Graham BS. Cell 167 625-631 (2016)
- Dengue: knowledge gaps, unmet needs, and research priorities. Katzelnick LC, Coloma J, Harris E. Lancet Infect Dis 17 e88-e100 (2017)
- Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Priyamvada L, Hudson W, Ahmed R, Wrammert J. Emerg Microbes Infect 6 e33 (2017)
- Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host. Kuhn RJ, Dowd KA, Beth Post C, Pierson TC. Virology 479-480 508-517 (2015)
- The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis. Heinz FX, Stiasny K. Microbiol. Mol. Biol. Rev. 81 (2017)
- The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. Rey FA, Stiasny K, Vaney MC, Dellarole M, Heinz FX. EMBO Rep. 19 206-224 (2018)
- Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine. Shukla R, Ramasamy V, Shanmugam RK, Ahuja R, Khanna N. Front Cell Infect Microbiol 10 572681 (2020)
- Immune Response to Dengue and Zika. Ngono AE, Shresta S. Annu. Rev. Immunol. 36 279-308 (2018)
- Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens. Liljeroos L, Malito E, Ferlenghi I, Bottomley MJ. J Immunol Res 2015 156241 (2015)
- The role of Fc receptors in HIV prevention and therapy. Boesch AW, Brown EP, Ackerman ME. Immunol. Rev. 268 296-310 (2015)
- Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development. Acosta EG, Bartenschlager R. Expert Rev Vaccines 15 467-482 (2016)
- Molecular basis of antibody-mediated neutralization and protection against flavivirus. Dai L, Wang Q, Qi J, Shi Y, Yan J, Gao GF. IUBMB Life 68 783-791 (2016)
- Zika Virus Structure, Maturation, and Receptors. Sirohi D, Kuhn RJ. J. Infect. Dis. 216 S935-S944 (2017)
- Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity. VanBlargan LA, Goo L, Pierson TC. Microbiol. Mol. Biol. Rev. 80 989-1010 (2016)
- Immune correlates for dengue vaccine development. Srikiatkhachorn A, Yoon IK. Expert Rev Vaccines 15 455-465 (2016)
- Recent advances in understanding dengue. Yacoub S, Mongkolsapaya J, Screaton G. F1000Res 5 (2016)
- Cryo-EM Studies of Virus-Antibody Immune Complexes. Li N, Li Z, Fu Y, Cao S. Virol Sin 35 1-13 (2020)
- Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Khandia R, Munjal A, Dhama K, Karthik K, Tiwari R, Malik YS, Singh RK, Chaicumpa W. Front Immunol 9 597 (2018)
- The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis. Gan ES, Ting DH, Chan KR. Expert Rev Anti Infect Ther 15 111-119 (2017)
- Cross-Reactive Immunity Among Flaviviruses. Rathore APS, St John AL. Front Immunol 11 334 (2020)
- Molecular Insights into the Flavivirus Replication Complex. van den Elsen K, Quek JP, Luo D. Viruses 13 956 (2021)
- Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections. Zhang X, Jia R, Shen H, Wang M, Yin Z, Cheng A. Viruses 9 (2017)
- The immune response against flaviviruses. Slon Campos JL, Mongkolsapaya J, Screaton GR. Nat. Immunol. 19 1189-1198 (2018)
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine. Screaton G, Mongkolsapaya J. Cold Spring Harb Perspect Biol 10 (2018)
- Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development. Tsai WY, Lin HE, Wang WK. Front Microbiol 8 1372 (2017)
- Dengue: an update on treatment options. Chan CY, Ooi EE. Future Microbiol 10 2017-2031 (2015)
- Development of Antibody Therapeutics against Flaviviruses. Sun H, Chen Q, Lai H. Int J Mol Sci 19 (2017)
- Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms. Jin J, Simmons G. Clin. Vaccine Immunol. 23 535-539 (2016)
- The Development of Peptide-based Antimicrobial Agents against Dengue Virus. Huang YW, Lee CT, Wang TC, Kao YC, Yang CH, Lin YM, Huang KS. Curr. Protein Pept. Sci. 19 998-1010 (2018)
- A comprehensive review on staphylococcal protein A (SpA): Its production and applications. Rigi G, Ghaedmohammadi S, Ahmadian G. Biotechnol Appl Biochem 66 454-464 (2019)
- Current status and perspectives on vaccine development against dengue virus infection. Park J, Kim J, Jang YS. J Microbiol 60 247-254 (2022)
- Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy. Kok BH, Lim HT, Lim CP, Lai NS, Leow CY, Leow CH. Virus Res 324 199018 (2023)
- Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era? Galula JU, Salem GM, Chang GJ, Chao DY. Hum Vaccin Immunother 15 2328-2336 (2019)
- Flavivirus: From Structure to Therapeutics Development. Zhao R, Wang M, Cao J, Shen J, Zhou X, Wang D, Cao J. Life (Basel) 11 615 (2021)
- Protection against dengue virus requires a sustained balance of antibody and T cell responses. Valentine KM, Croft M, Shresta S. Curr Opin Virol 43 22-27 (2020)
- Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design? Wilken L, Rimmelzwaan GF. Pathogens 9 (2020)
- Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Joseph J, Sandel G, Kulkarni R, Alatrash R, Herrera BB, Jain P. Pathogens 13 14 (2023)
- Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus. Jin J, Simmons G. Viruses 11 (2019)
- Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention. Blight J, Alves E, Reyes-Sandoval A. Vaccines (Basel) 7 (2019)
- Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement. Sarker A, Dhama N, Gupta RD. Front Immunol 14 1200195 (2023)
- Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics. Anasir MI, Poh CL. Med Microbiol Immunol 211 1-18 (2022)
- Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development. Dussupt V, Modjarrad K, Krebs SJ. Front Immunol 11 621043 (2020)
- Microbiology catches the cryo-EM bug. Earl LA, Falconieri V, Subramaniam S. Curr. Opin. Microbiol. 43 199-207 (2018)
- Morphological Diversity and Dynamics of Dengue Virus Affecting Antigenicity. Fibriansah G, Lim XN, Lok SM. Viruses 13 1446 (2021)
- Naïve Human Antibody Libraries for Infectious Diseases. Chan SK, Rahumatullah A, Lai JY, Lim TS. Adv Exp Med Biol 1053 35-59 (2017)
- The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity. Dowd KA, Pierson TC. Annu Rev Virol 5 185-207 (2018)
- Viral-Induced Enhanced Disease Illness. Smatti MK, Al Thani AA, Yassine HM. Front Microbiol 9 2991 (2018)